Sinopharm: Influenza, Human trials
The registry lists 15 Influenza, Human studies with Sinopharm as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 6Phase 3 1Phase 4 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and AboveNot yet recruitingNCT07327398Phase 2
- A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and AboveRecruitingNCT07302256Phase 1
- A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.CompletedNCT06342349Phase 1
- To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 YearsStatus unknownNCT05389137Phase 4
- Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 YearsCompletedNCT05138705Phase 4
- Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4Status unknownNCT05079152Phase 4
- Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4CompletedNCT04790851Phase 4
- Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4CompletedNCT04559204Phase 4
- Clinical Trial of Quadrivalent Influenza Virus Split VaccineCompletedNCT04363359Phase 2
- Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedNCT04091880Phase 4
- A Study of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03755427Phase 2
- A Clinical Trial of A Quadrivalent Influenza VaccineCompletedNCT03744104Phase 3
- A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03369808Phase 1/2
- Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in InfantsCompletedNCT01494740Phase 2
- The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 VaccineCompletedNCT01336166Phase 2